MORGAN STANLEY PLC/CALL/MEDTRONIC/130/0.1/20.12.24 Share Price

Warrant

DE000MB8SLF3

Market Closed - Börse Stuttgart 10:01:45 03/07/2024 pm IST
0.054 EUR 0.00% Intraday chart for MORGAN STANLEY PLC/CALL/MEDTRONIC/130/0.1/20.12.24
Current month+28.57%
1 month+134.78%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
03/24/03 0.054 0.00%
02/24/02 0.054 +31.71%
01/24/01 0.041 -2.38%
28/24/28 0.042 +2.44%
27/24/27 0.041 0.00%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 10:01 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying MEDTRONIC PLC
Issuer Morgan Stanley
WKN MB8SLF
ISINDE000MB8SLF3
Date issued 14/07/2023
Strike 130 $
Maturity 20/12/2024 (170 Days)
Parity 10 : 1
Emission price 0.11
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.16
Lowest since issue 0.012
Delta0.07x
Omega 8.368
Premium69.25x
Gearing126.69x
Moneyness 0.5936
Difference Strike 52.83 $
Difference Strike %+40.64%
Spread 0.009
Spread %14.75%
Theoretical value 0.0565
Implied Volatility 44.75 %
Total Loss Probability 96.46 %
Intrinsic value 0.000000
Present value 0.0565
Break even 130.61 €
Theta-0.01x
Vega0.01x
Rho0x

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
77.17 USD
Average target price
94.02 USD
Spread / Average Target
+21.84%
Consensus